Superworth

TransMedics price to free cash flow TMDX

Market value divided by free cash flow over the last twelve months, since 2025.

Today, Nov 2, 2026
29.2×
Peer median
21.0×

TransMedics' price to free cash flow is 29.2× as of Nov 2, 2026.

The median for 4 medical device stocks of a similar size is 21.0×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far29.2×14.4×41.6×
202535.2×32.6×256×

Against its peers

Companies in Medical - Devices nearest TransMedics' size, closest first, today.

CompanyPrice to free cash flow
TMDXTransMedics29.2×
CNMDCONMED10.5×
ITGRInteger52.6×
LIVNLivaNova29.8×
ZBHZimmer Biomet12.2×
Peer median21.0×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on TransMedics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.